C14orf39 Inhibitors
C14orf39 inhibitors target various signaling pathways that may exert influence over its function or localization within cellular processes. Compounds like Wortmannin and LY294002, known to inhibit PI3K, can indirectly modulate C14orf39. Similarly, inhibitors like PD98059 and U0126 can act upon it.
The function and cellular localization of proteins often relate to calcium concentrations. Hence, calcium chelators like BAPTA-AM can be of relevance. Rapamycin, an mTOR inhibitor, highlights the intricacies of protein networks. The Wnt signaling pathway, modulated by IWP-2, and Rho signaling, influenced by Y-27632, are other pivotal cellular pathways that, when interrupted, might cast ripples affecting C14orf39's function.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
If C14orf39 is involved in PI3K signaling, Wortmannin can modulate its activity indirectly. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Similar to Wortmannin, if C14orf39 is associated with PI3K pathways, LY294002 can act as an indirect inhibitor. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
If C14orf39 plays a role in the MAPK pathway, PD98059 can indirectly affect its functionality. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK pathways, if related to C14orf39's function, can be modulated by SP600125. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
Can indirectly modulate C14orf39 if it's involved in the p38 MAPK pathway. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
If C14orf39 is associated with mTOR signaling, Rapamycin can serve as an indirect modulator. | ||||||
Akt Inhibitor VIII, Isozyme-Selective, Akti-1/2 | 612847-09-3 | sc-202048 sc-202048A | 1 mg 5 mg | $208.00 $270.00 | 29 | |
By inhibiting Akt, this compound can impact downstream targets, possibly including C14orf39 if related. | ||||||
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $458.00 | 61 | |
If C14orf39 is calcium-dependent or involved in calcium signaling, BAPTA-AM can indirectly influence it. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Potential modulator of C14orf39 if it's associated with Rho signaling pathways. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
May affect C14orf39 if it is involved in Src-related signaling. | ||||||